TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 6 filers reported holding TRINITY BIOTECH INVT LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 48,000,000 | $38,917,000 | 1.50% |
Wellesley Asset Management | 29,650 | $23,979,000 | 1.25% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 23,425,000 | $19,091,000 | 0.28% |
LINDEN ADVISORS LP | 8,590,000 | $7,034,000 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 850,000 | $699,000 | 0.03% |
Citadel Advisors | 4,000,000 | $3,264,000 | 0.00% |